Close this search box.

Product Roadmap

Explore Lifespin’s Product Roadmap, detailing the development of our deep health platform. Follow our journey towards creating an omni-intelligent, agnostic health analysis solution for comprehensive and personalized healthcare.

lifespin deep health platform development roadmap

Building towards an omni-intelligent and agnostic health analysis platform
lifespin‘s AI platform is an advanced self-learning system that evaluates health by comparing patient‘s blood profiles against its proprietary disease pattern database based on metabolomics.
* Diseases detected with high reliability (cutoff AUC value higher 0.8) based on clinical studies.

Contact us for more information for partnering and investment opportunities, alternatively, explore the comprehensive list of benefits

Scroll to Top

Dr. Roland Geyer

10+ years experience in NMR-based metabolomics and diagnostic.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Ali Tinazli

CEO, lifespin GmbH

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).